Famotidine Powder, For Suspension
Product Images NDC 69238-2090

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 69238-2090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Famotidine For Oral Suspension Usp 1)

Chemical structure diagram of famotidine, illustrating its molecular arrangement including functional groups and bond connections as seen in the formula.*

FDA Label Image

Label (Famotidine For Oral Suspension Usp 2)

This label panel provides reconstitution instructions, storage conditions, and usage warnings for Famotidine for Oral Suspension, USP 40 mg/5 mL. It states to add 46 mL of purified water and shake vigorously, store between 20° to 25°C, discard after 30 days, and shake well before use. The label also notes the bottle is oversized for shaking and is distributed by Amneal Pharmaceuticals LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.